It is a great pleasure to invite you to the upcoming 4th Congress of the International Society for Infectious Diseases in Obstetrics and Gynecology, ISIDOG, to be held between 14th and 17th October, 2021 in Budapest, Hungary.
Due to the challenges of the global Sars-COV-2 pandemic and the still unknown proportion of vaccinated percentage by the time of our scheduled meeting, new methods of organization of our congress had to be introduced. Thus, a hybrid meeting will be organized with members of the Board of ISIDOG on site, and those having interest in the magic world of infectious diseases in obstetrics and gynecology either in person in Budapest or in front of the screens. Certainly, this novel frame of meeting needs a great deal of openness and flexibility from both participants and organizers in order not to miss the regular scientific platform to discuss new challenges in our field. Also the continued and unconditional support of our sponsors is crucial and most welcome. The structure of the conference is based on our familiar structure with a pre-congress National Day on 14th October held in Hungarian, followed by two days of the core ISIDOG meeting. On day 2 and 3 plenary sessions by invited speakers, lunch symposia, free communication and poster session will be presented. On Sunday an extremely exciting Science-Meets the Industry meeting will be organized.
What else could be the main topic of the 4th ISIDOG Congress in 2021 than Sars-COV-2 infections before, during and after pregnancy?
Additional topics include diagnosis and treatment of lower genital tract infections, role of non-antibiotic treatment of vaginal disorders, an update on Candida vaginitis, sexually transmitted viral and bacterial infections and latest data on HPV vaccination.
Pharma industry will find a wide spectrum of communication with the congress participants via online tools including short films, videos and web links to their new products and procedures. In addition, round table discussions for new drugs, antibiotics and novel treatment protocols as well as diagnostic methods will also be available.
On behalf of the Board of ISIDOG and the Hungarian Society of Obstetricians and Gynecologists as local organizer we truly hope that old and new friends of infectious diseases in obstetrics and gynecology will be motivated and enthusiastic to find a new occasion for get together and discuss latest data for the sake of women’s health.
Look forward to greeting you in Budapest,
 |  |
| Prof. Dr. István Sziller Congress Organizing Committee | Prof. Dr. Gilbert Donders President of ISIDOG |
Hungarian Society for Obstetrics and Gynecology
Prof. G. Donders
Dr. P. Greenhouse
Prof. W. Mendling
Prof. L. Petricevic
Prof. D. Rezeberga
Prof. I. Sziller
Dr. Zs. Melczer
Dr. E. Balla
Dr. V. Karaszi
Dr. A. Ujhazy
The ISIDOG 2021, Budapest, Hungary 14/10/2021-17/10/2021 event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 11 European CME credits. (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actaully spent in the educational activity.
COVID infection before, during and after pregnancy
COVID infection and fertility
Vaginal microbiome in health and disease
HPV vaccination – update
Candida vaginitis – update
Intra-amniotic infection caused by bacteria and viruses
Chronic recurrent infections in out-patient gynecology
Bacterial STI’s
Miscellaneous
We would like to call your attention, that based on the current Hungarian regulations attendance to live indoor events is limited to participants who present their valid COVID certificate and identity card. Please, prepare your documents and show them at the congress registration desk.
Please indicate whether your paper has been submitted for publication or has been published.
Abstracts received within the deadline will be published in the abstract book.
Abstracts should be limited to 3000 characters, and may include a table or figure.
List the names of the authors, with affiliation, specify the presenting author.
Use structured abstract headings: Introduction/Aim – Methods/Patients – Results - Discussion
Abstracts should have no more than 6 references (to be counted in the maximum number of characters).
Abstract deadline August 15, 2021.
For presentation only slides with PC-compatible technology (MS Powerpoint) will be accepted.
Your abstract can only be considered after you registered and paid for the conference.
Thursday 14 October | |
| 09.00-17.00 | ISIDOG Hungary Educational Day (in Hungarian) |
| 18.30-20.00 | IV ISIDOG CONGRESS Session 1 OPENING WELCOME & KEYNOTE LECTURE |
Friday 15 October | |
| 08.30-09.15 | Session 2: Free Oral Communications #1 (Pregnancy) |
| 09.30-10.45 | Session 3: Obstetric & Neonatal Microbiology |
| 11.00-12.15 | Session 4: Prevention of Materno-Fetal Infection |
| 12.30-13.30 | Session 5: Lunch Symposium by Medinova |
| 14.00-15.15 | Session 6: Free Oral Communications #2 (Vaginitis) |
| 15.30-16.45 | Session 7: Vulvo-Vaginal Infections #1 |
| 17.00-18.15 | Session 8: Vulvo-Vaginal Infections #2 |
Saturday 16 October | |
| 08.30-09.45 | Session 9: Free Oral Communications #3 (Candida etc.) |
| 10.00-11.30 | Session 10: Sexually Transmitted Infections |
| 11.45-12.45 | Session 11: Lunch Symposium by Bayer |
| 13.00-14.00 | Session 12: Lunch Symposium by Gedeon Richter |
| 14.15-15.30 | Session 13: Pro- and Pre-Biotics |
| 15.45-17.00 | Session 14: COVID impact on Women’s Health |
| 17.15-17.30 | CLOSING AND PRIZES |
Sunday 17 October | |
| 09.30-12.30 | Session 15: Science meets Industry |
09.00-17.00 |
09.10-10.20 |
| Management of severe COVID infection in pregnancy Nandor Acs (Budapest, HU) |
| COVID vaccination in pregnancy and the puerperium Zsolt Melczer (Budapest, HU) |
| Impact of maternal COVID on the placenta Zsofia Zolnai (Budapest, HU) |
10.50-11.50 |
| Prevention of pre-term birth Udo Hoyme (Erfurt, DE) |
| Immunization in Pregnancy Marta Csire, Artur Beke (Budapest, HU) |
| Lymphocytic choriomeningitis in neonates Orsolya Nagy (Budapest, HU |
11.50-13.10 |
| Symposium sponsored by MSD Indications for HPV Vaccination in 2021 Robert Koiss (Budapest, HU) |
| Local treatment of cervical HPV Gabor Sobel (Budapest, HU) |
| RNA-based HPV diagnostics Kiarash Bahremand (Budapest, HU) |
| Relationship between patients HPV screening results and their cytological findings Balazs Hamar (Budapest, HU) |
14.00-15.15 |
| Pathogenesis of recurrent vaginal infections Magdolna Gaal (Szeged, HU) |
| Coitally-associated recurrent vaginal infection Andras Ujhazy (Budapest, HU) |
| Symposium sponsored by Bausch Health Treatment of vaginal infections without antibiotics Zsolt Melczer (Budapest, HU) |
15.45-17.00 |
| Congenital syphilis: national data & laboratory diagnosis Eszter Balla (Budapest, HU) |
| Syphilis in non-pregnant women Viktoria Varkonyi (Budapest, HU) |
| Inpatient management of Pelvic Inflammatory Disease Istvan Sziller Istvan (Budapest, HU) |
| The first female case of LGV in Hungary Toth Bela (Budapest, HU) |
IV ISIDOG CONGRESS18.30-19.30 |
| Welcome Introduction Gilbert Donders (BE) & Istvan Sziller (HU) |
| Laudatio - Bill Ledger Steven Witkin (US) |
| Keynote Lecture: How COVID affects Gynecology & Medicine Marleen Temmerman (Kenya) |
19.30 |
21.00 |
08.30-09.20 |
| F.1 Mixed vaginitis in 3rd trimester of pregnancy is associated with adverse pregnancy outcomes: A cross-sectional study. Li Huanrong, Xue Fengxia (Tianjin, PRC) |
| F.2 Do pregnant women with obstetric medical history have a vaginal microbiome associated with higher recurrence risk of preterm birth? Sanne Laurijssen, Gilbert Donders, Yves Jacquemyn, Sarah Lebeer (Antwerp, BE) |
| F.3 In-vitro study of polybacterial infection of chorioamniotic membranes: modulation of immune response at maternal-fetal interface. Giovana Bento, Mariana de Castro Silva, Geovanna Cristofani Cursino, Carolina Santimaria Rampazzo, Guiherme Nastaro, Jossimara Polettini, Marcia Guimarães da Silva (São Paolo, BR) |
09.30-10.45 |
| Chorio-Amnionitis Marian Kacerovsky (CZ) |
| Vaginitis/Vaginosis in pregnancy in East Congo Lisa Himschoot (BE) |
| Vaginal viruses in pregnancy Steven Witkin (US) |
| Caesarean section, microbiome & childhood development Daniel Surbek (CH) |
11.15-12.30 |
| Mycoplasma genitalium in women in Germany Anja Potthoff (DE) |
| Maternal immunization Kirsten Maertens (BE) |
| SARS-CoV-2 vaccination Svitrigaile Grinceviene (LT) |
| Clinical conundrum: Two maternal sepsis deaths Peter Greenhouse (GB) |
12.45-13.45 |
| Update on “ProPreB” trial Prof. Gilbert Donders (BE) |
| Management of abnormal flora in pregnancy Prof. Daniel Surbek (CH) |
14.00-15.20 |
| F.4 Aerobic Vaginitis diagnosis criteria combining Gram stain with clinical features: An establishment and prospective validation study Dong Mengting (Tianjing, PRC) |
| F.5 Vaginal microbial profiles of Aerobic Vaginitis: A case-control study Wang Chen (Tianjing, PRC) |
| F.6 Characteristics & diagnostic ability of vaginal microflora in patients with Aerobic Vaginitis: A comparative study with 16S-RNA sequencing Zeng Zhen, Zhang Qiongqiong, Zhang Lei (Beijing, PRC) |
| F.7 Cervicovaginal load of Gardnerella spp. is increased in immunocompetent women with persistent high-risk HPV Infection Rafael Belleti, Larissa Doddi Marcolino, Juliano Novak, Carolina Sanitá Tafner Ferreira, Aline do Nascimento Bolpetti, Gabriel da Silva Pinto, Gabriel Vitor, Ana Cristina Palmeira de Oliveira, Marcia Guimarães da Silva, Camila Marconi (São Paolo, BR) |
| F.8 Association of vaginal microecology and Cervical Intraepithelial Neoplasia among reproductive women with high-risk HPV Infection. Li Huiyang, Xie Wenjuan, Dong Mengting (Tianjing, PRC) |
| F.9 The use of menstrual cups is associated with the maintenance of healthy vaginal microbiota. Bruna Ribeiro de Andrade Ramos, Júlia Abbade Tronco, Jeniffer Sena Baptista Ferreira, Mariana de Castro Silva, Mariana Alice de Oliveira Ignácio, Beatriz Cassolatti Graciolli, Marli Terezinha Cassamassimo Duarte, Márcia Guimarães Da Silva (São Paolo, BR) |
15.30-16.45 |
| Clinical recommendations on mixed vaginitis Qi Wenhui (PRC) |
| Lichen sclerosus and vulvodynia Werner Mendling (DE) |
| Treatment options for bacterial vaginosis Jack Sobel (US) |
17.00-18.00 |
| What can we learn from vaginal microbiome analysis? Sarah Lebeer (BE) |
| Isala project: citizen-science mapping of the vaginal microbiome structure and determinants Sarah Ahannah (BE) |
| Aerobic Vaginitis as an immune disorder Werner Mendling (DE) |
20.00 |
08.30-09.50 |
| F.10 Advances in vaginal microecology theory in the application of vulvovaginal candidiasis. Ma Xiaotong (Tianjing, PRC) |
| F.11 Candida biofilms in vulvovaginal candidiasis. Carmen Rodriguez-Cerdeira, Roberto Arenas (Vigo, ES) |
| F.12 Three phase 3, randomized, double-blind, placebo-controlled studies to evaluate the efficacy and safety of Oteseconazole (Vt-1161) oral capsules in subjects with recurrent vulvovaginal candidiasis. Gilbert Donders, Jack Sobel, Mark Martens, Bassem Maximos, Mahmoud Ghannoum, Amy Flynt, Thorsten Degenhardt, Karen Person, Stacey Curelop, Stephen Brand (Antwerp, BE) |
| F.13 Efficacy and safety of oral Ibrexafungerp in subjects with vulvovaginal candidiasis: Pooled data analysis from two phase 3, randomized, blinded, studies vs. placebo (VANISH-303 and VANISH-306). Nkechi Azie, David Angulo (US) |
| F.14 Dyspareunia in women: is it always vulvodynia? Jente Reumers, Gilbert Donders, Francesca Donders (Tienen, BE) |
10.00-11.30 |
| Access to STI & HIV testing during the COVID-19 restrictions Dace Rezeberga (LV) |
| HPV and fertility Christophe Depuydt (BE) |
| Rectal & extra-genital chlamydial infection - “FemCure” Study Nicole Dukers-Muijrers (NL) |
| HPV and genital cancer in LBGTQIA+ populations Mikael Skerlev (HR) |
| Sex parties and STI prevalence Tatiana Ivanova-Rumantseva (RF) |
11.45-12.45 |
| Vaginal and gut microbiome – a cross talk Prof. Werner Mendling (DE) |
| Managing women with recurrent bacterial vaginosis: how does the VITA trial (lactic acid gel versus metronidazole) help inform practice Prof. Jonathan Ross (GB) |
13.00-14.00 |
| RVVC: Towards an optimised diagnosis Prof. Istvan Sziller (HU) |
| RVVC: Towards an optimised therapeutic approach Prof. Gilbert Donders (BE) |
14.15-15.30 |
| Antifungals versus probiotrics against candidal vaginitis? Sarah Lebeer (BE) |
| Do oral probiotics influence the vaginal microbiome? Ljubomir Petricevic (AT) |
| Testing of pre- and pro-biotic treatments Joana Rolo (PT) |
| Gardenella-specific endolysin treatment of metronidazole-resistant and clindamycin-tolerant bacterial vaginosis Lorenzo Corsini (IT) |
15.45-17.00 |
| COVID and sperm Jente Reumers (BE) |
| ISIDOG guidelines for COVID in pregnancy Francesca Donders (BE) |
| COVID and the placenta Zsofia Zolnai (HU) |
| Impact of social media & COVID on STI epidemiology Peter Greenhouse (GB) |
17.15-17.30 |
09.30-12.30 |
(inlcuding Hungarian VAT, 27%)
| Online | Onsite | |
| Registation fee | EUR 180 | EUR 250 |
| Registration fee for ISIDOG members | EUR 125 | EUR 180 |
| Pre-Congress registration fee (for Hungarian day) | EUR 50 | EUR 50 |
| Registration fee for residents, nurses | EUR 75 | EUR 120 |
| Reduced registration fee (dedicated countries only) | EUR 75 | EUR 120 |
| Lunch on 15th October | - | EUR 23 |
| Lunch on 16th October | - | EUR 23 |
| Danubius Hotel Helia (congress venue) 1133 Budapest Kárpát u. 62-64., Hungary | Phone: +36-1-889-5900 | |
| Standard room for 1 person with breakfast and VAT | 90 EUR /room /night |
| Standard room for 2 person with breakfast and VAT | 100 EUR /room /night |
| Additional charges for other services | |
| Danube River panorama | 10 EUR /room /night |
| Room with balcony | 20 EUR /room /night |
| Parking | 10 EUR /car /day |
| Booking form to be found at the Downloads section | |
Notice of cancellation must be received in writing before October 1, 2021. EUR 25 administrative fee is nonrefundable. No refunds will be administered after October 1, 2021. The cancellation policy is further defined on registration site in the Terms and Conditions.
Ms. Katalin Vámos
Key account manager
E-mail: kvamos@convention.hu
Phone: (+36 30) 576 6031
Prof. István Sziller
E-mail: isziller@gmail.com
Convention Budapest Ltd.
H-1143 Besnyői street 13. 1st. floor
Budapest, Hungary
Phone: (+36 1) 299 0184, 299 0185
Fax: (+36 1) 299 0187
www.convention.hu
